Tag: Human Papilloma Virus (HPV)

1. In this national survey, both pediatricians and family physicians (FPs) were more likely to make a strong recommendation for ...

Genetically engineered T-cell therapies, such as chimeric antigen receptor T-cells (CAR T-cells), have been approved for the treatment of hematologic ...

1. A 3-dose regimen of 4-valent human papillomavirus (4vHPV) vaccine administered between the ages of 9-15 years of age was shown ...

1. Physicians who used an announcement technique when introducing human papillomavirus (HPV) vaccination had a higher rate of vaccination coverage ...

1. A greater proportion of teenage girls initiated the human papillomavirus (HPV) vaccine series in states where the tetanus, diphtheria, ...

1. There was a significant decline noted in the prevalence of the human papillomavirus (HPV) types 6, 11, 16, and 18 ...

1. In U.S. adolescent males, human papillomavirus (HPV) vaccination uptake of ≥1 dose and series completion of ≥3 doses were ...

1. Simultaneous administration of the 9-valent human papillomavirus (HPV) vaccine with Tdap (tetanus/diphtheria/acellular pertussis) and Menactra (Neisseria meningitidis) resulted in ...

1. Radiographic evidence of matted nodes was a significant independent predictor for distant failure and case-specific mortality in patients who ...

1. Oral oncogenic HPV prevalence was more than 4 times higher among men than women. 2.The gender difference was due primarily ...